איקלוסיג 45 מג ישראל - עברית - Ministry of Health

איקלוסיג 45 מג

incyte biosciences israel ltd, israel - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 45 mg - ponatinib

איקלוסיג 45 מג ישראל - עברית - Ministry of Health

איקלוסיג 45 מג

incyte biosciences israel ltd, israel - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 45 mg - ponatinib

מטוג'קט 50 מג  מל תת עורי ישראל - עברית - Ministry of Health

מטוג'קט 50 מג מל תת עורי

tzamal bio-pharma ltd - methotrexate - תמיסה להזרקה - methotrexate 50 mg/ml - methotrexate - methotrexate - psoriasis in adult patients :because of the high risk attending its use, methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. rheumatoid arthritis: methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose nsaids and usually a trial of at least one or more disease-modifying antirheumatic drugs.juvenile idiopathic arthritis:treatment of polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (nsaids) has been inadequate

מטוג'קט 50 מג  מל תת עורי ישראל - עברית - Ministry of Health

מטוג'קט 50 מג מל תת עורי

tzamal bio-pharma ltd - methotrexate - תמיסה להזרקה - methotrexate 50 mg/ml - methotrexate - methotrexate - psoriasis in adult patients :because of the high risk attending its use, methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. rheumatoid arthritis: methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose nsaids and usually a trial of at least one or more disease-modifying antirheumatic drugs.juvenile idiopathic arthritis:treatment of polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (nsaids) has been inadequate

מטוג'קט 50 מג  מל תת עורי ישראל - עברית - Ministry of Health

מטוג'קט 50 מג מל תת עורי

tzamal bio-pharma ltd - methotrexate - תמיסה להזרקה - methotrexate 50 mg/ml - methotrexate - methotrexate - psoriasis in adult patients :because of the high risk attending its use, methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. rheumatoid arthritis: methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose nsaids and usually a trial of at least one or more disease-modifying antirheumatic drugs.juvenile idiopathic arthritis:treatment of polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (nsaids) has been inadequate

מטוג'קט 50 מג  מל תת עורי ישראל - עברית - Ministry of Health

מטוג'קט 50 מג מל תת עורי

tzamal bio-pharma ltd - methotrexate - תמיסה להזרקה - methotrexate 50 mg/ml - methotrexate - methotrexate - psoriasis in adult patients :because of the high risk attending its use, methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. rheumatoid arthritis: methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose nsaids and usually a trial of at least one or more disease-modifying antirheumatic drugs.juvenile idiopathic arthritis:treatment of polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (nsaids) has been inadequate

מטוג'קט 10 מ"ג /מ"ל ישראל - עברית - Ministry of Health

מטוג'קט 10 מ"ג /מ"ל

tzamal bio-pharma ltd - methotrexate 10 mg/ml - solution for injection - methotrexate - psoriasis:because of the high risk attending its use, methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. rheumatoid arthritis: methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose nsaids and usually a trial of at least one or more disease-modifying antirheumatic drugs.

מטוג'קט 50 מ"ג / מ"ל ישראל - עברית - Ministry of Health

מטוג'קט 50 מ"ג / מ"ל

tzamal bio-pharma ltd - methotrexate 50 mg/ml - solution for injection - methotrexate - psoriasis:because of the high risk attending its use, methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. rheumatoid arthritis: methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose nsaids and usually a trial of at least one or more disease-modifying antirheumatic drugs.juvenile idiopathic arthritis:treatment of polyarthritic forms of severe, active juvenile idiopathic arthritis when the response to non-steroidal anti-inflammatory drugs (nsaids) has been inadequate

ProSpace™ ישראל - עברית - Ministry of Health

prospace™

bioprotect ltd. - רופא - הפרדה בין רקמות בריאות וחולות בזמן ביצוע הקרנה לטיפול בחולי סרטן הערמונית

סימדקס 2.5 מגמל ישראל - עברית - Ministry of Health

סימדקס 2.5 מגמל

bio-med - j.r ltd, israel - levosimendan - תרכיז להכנת תמיסה לאינפוזיה - levosimendan 2.5 mg/ml - levosimendan - levosimendan - therapeutic indications: short-term treatment of acutely decompensated severe chronic heart failure.simdax should only be used as add-on therapy in situations where conventional therapy with e.g. diuretics, ace-inhibitors and digitalis is not sufficient and where there is a need for inotropic support.